Last reviewed · How we verify
NCT06576453: Pepps_Mix
Mixed-method Evaluation of a Parental Psychoeducation Programme in a Suicide Risk Prevention Group
trial testing Self-questionnaire WHOQOL-bref in Suicide Prevention in 40 participants. Currently enrolling.
30 June 2025
Quick facts
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 23 May 2024 |
| Primary completion | 30 June 2025 |
| Estimated completion | 31 July 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Self-questionnaire WHOQOL-bref
- Self-questionnaire Evaluation Inventory - Parent
- quiz of knowledge
- semi-structured interviews (qualitative)
Conditions studied
- Suicide Prevention — all drugs for Suicide Prevention →
Sponsor
Assistance Publique - Hôpitaux de Paris — full company profile →
Who can join
18 and older, any sex, with Suicide Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The number of emergency consultations for children and adolescents for suicidal ideation and suicide attempts has been rising steadily since 2010, and even more so since 2020. In addition, 30% of children and adolescents who have committed a suicidal act reoffend within the year. Psycho-education programmes for patients have been shown to be effective in a large number of psychiatric pathologies. The programs of psychoeducation for the caregivers of these patients have them also shown their effectiveness, however to date there is no parental psychoeducation program group, for the prevention of the suicidal risk of children and adolescents, which is validated. The service of child psychiatry at the Robert Debré hospital built a program for this purpose, according to current data from the science and has been offering it for 6 months to parents of patients who consulted for suicidal ideation. Rate this program through the description of its implementation would allow it to be validated, this in a dissemination objective. This validation through a mixed method would also allow us to describe the experience participants in this program and to understand improvements Track.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06576453
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicide Prevention
Currently open trials in the same condition.
- NCT07219355 — Virtual Reality Lethal Means Safety Training · NA · recruiting
- NCT07286955 — Life Skills Training for Soldiers Arriving at Their First Duty Location · NA · recruiting
- NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting
- NCT07259408 — Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior · recruiting
- NCT06596044 — Suicide Prevention After Community Care Discharge · NA · recruiting
Other Assistance Publique - Hôpitaux de Paris trials
Trials by the same sponsor.
- NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
- NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
- NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
- NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
- NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06576453 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
- Last refreshed: 28 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06576453.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing